I agree that this site is using cookies. You can find further informations here.
X
El‐Beshlawy, Amal
110  results:
Search for persons X
?
1

Deferiprone versus deferoxamine for transfusional iron over..:

Hamdy, Mona ; El‐Beshlawy, Amal ; Veríssimo, Mônica P. A....
Pediatric Blood & Cancer.  71 (2023)  1 - p. , 2023
Link: https://doi.org/10.1002/..
 
?
2

Management of haemophilia A with inhibitors: A regional cro..:

Peyvandi, Flora ; Kavakli, Kaan ; El‐Beshlawy, Amal.
Haemophilia.  28 (2022)  6 - p. 950-961 , 2022
Link: https://doi.org/10.1111/..
 
?
3

Risk of mortality from anemia and iron overload in nontrans..:

Musallam, Khaled M. ; Vitrano, Angela ; Meloni, Antonella...
American Journal of Hematology.  97 (2021)  2 - p. , 2021
Link: https://doi.org/10.1002/..
 
?
4

Primary HBB gene mutation severity and long‐term outcomes i..:

Musallam, Khaled M. ; Vitrano, Angela ; Meloni, Antonella...
British Journal of Haematology.  196 (2021)  2 - p. 414-423 , 2021
Link: https://doi.org/10.1111/..
 
?
5

Performance of a clinical risk prediction model for inhibit..:

Hassan, Shermarke ; Palla, Roberta ; Valsecchi, Carla...
Haemophilia.  27 (2021)  4 - p. , 2021
Link: https://doi.org/10.1111/..
 
?
6

A complication risk score to evaluate clinical severity of ..:

Vitrano, Angela ; Meloni, Antonella ; Addario Pollina, Walter...
British Journal of Haematology.  192 (2020)  3 - p. 626-633 , 2020
Link: https://doi.org/10.1111/..
 
?
7

Limitations of serum ferritin to predict liver iron concent..:

Porter, John B. ; Elalfy, Mohsen ; Taher, Ali...
European Journal of Haematology.  98 (2017)  3 - p. 280-288 , 2017
Link: https://doi.org/10.1111/..
 
?
8

Long‐term safety and efficacy of deferasirox in young pedia..:

Vichinsky, Elliott ; El‐Beshlawy, Amal ; Al Zoebie, Azzam...
Pediatric Blood & Cancer.  64 (2017)  9 - p. , 2017
Link: https://doi.org/10.1002/..
 
?
9

Prevalence and distribution of iron overload in patients wi..:

Aydinok, Yesim ; Porter, John B. ; Piga, Antonio...
European Journal of Haematology.  95 (2015)  3 - p. 244-253 , 2015
Link: https://doi.org/10.1111/..
 
?
10

Sustained improvements in myocardial T2* over 2 years in se..:

Pennell, Dudley J. ; Porter, John B. ; Piga, Antonio...
American Journal of Hematology.  90 (2014)  2 - p. 91-96 , 2014
Link: https://doi.org/10.1002/..
 
?
11

Multicenter validation of spin‐density projection‐assisted ..:

St Pierre, Tim G. ; El‐Beshlawy, Amal ; Elalfy, Mohsen...
Magnetic Resonance in Medicine.  71 (2013)  6 - p. 2215-2223 , 2013
Link: https://doi.org/10.1002/..
 
?
12

A dose‐escalation phase IIa study of 2,2‐dimethylbutyrate (..:

Kutlar, Abdullah ; Reid, Marvin E. ; Inati, Adlette...
American Journal of Hematology.  88 (2013)  11 - p. , 2013
Link: https://doi.org/10.1002/..
 
?
13

Differentiation of bone marrow hematopoietic stem cells int..:

Gabr, Hala ; Zayed, Rania ; ElBeshlawy, Amal...
Comparative Clinical Pathology.  23 (2012)  1 - p. 193-198 , 2012
Link: https://doi.org/10.1007/..
 
?
14

Importance of optimal dosing ≥30 mg/kg/d during deferasirox..:

Taher, Ali ; Elalfy, Mohsen S. ; Al Zir, Kusai...
European Journal of Haematology.  87 (2011)  4 - p. 355-365 , 2011
Link: https://doi.org/10.1111/..
 
?
15

Achieving treatment goals of reducing or maintaining body i..:

Taher, Ali ; Elalfy, Mohsen S. ; Al Zir, Kusai...
European Journal of Haematology.  87 (2011)  4 - p. 349-354 , 2011
Link: https://doi.org/10.1111/..
 
1-15